CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    34

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,828.7056.700.65%
CAC 407,738.4275.830.99%
DAX 4023,790.11116.820.49%
Dow JONES (US)44,484.4210.52-0.02%
FTSE 1008,774.6910.64-0.12%
HKSE24,221.41149.130.62%
NASDAQ20,393.13190.240.94%
Nikkei 22539,762.48223.85-0.56%
NZX 50 Index12,732.9551.34-0.40%
S&P 5006,227.4229.410.47%
S&P/ASX 2008,597.7056.600.66%
SSE Composite Index3,454.792.95-0.09%

Market Movers